Clinical Medical Transformation Center
OriCell Therapeutics has established strategic cooperation with a number of domestic grade-A tertiary hospitals, combined with its own R&D experience in the field of solid tumor immunotherapy, to allow researchers, doctors, and patients to gather under one roof, establish a bridge between basic research and clinical application, and promote the transformation of clinical medicine in the field of solid tumor immunotherapy.
-
Shanghai General Hospital
Shanghai Engineering Technology Research Center for Cell Therapy Clinical Research and Transformation
Clinical research on TIL cells for treatment of malignant bone tumors
Clinical research on CAR-T cells and screening of related new targets
-
Zhongshan Hospital
Zhongshan OriCell Cell Therapy Center
Conduct IND clinical trials on immunocytotherapy for advanced liver cancer
-
Lishui Central Hospital
Cell Therapy Clinical Research and Transformation Center
Conduct non-IND clinical research on immunocytotherapy for advanced liver cancer
-
Changzheng Hospital
Changzheng OriCell Clinical Cell Research Center
Clinical research on TIL cells for treatment of malignant bone tumors
Clinical research on CAR-T cells and screening of related new targets
-
The First Affiliated Hospital of Zhejiang University School of Medicine
Conduct non-IND/IND clinical trials on CAR-T cell therapy for target site-2 in myeloma
